QUK

Human Leukocyte Antigen (Hla) Typing Companion Diagnostic Test

产品代码
QUK
器械名称
Human Leukocyte Antigen (Hla) Typing Companion Diagnostic Test
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 866.5960
FDA 专业组
Immunology
上市路径
需提交 510(k) 上市前通告

FDA 分类定义

A Human Leukocyte Antigen (HLA) Typing Companion Diagnostic (CDx) Test is a prescription genotyping or phenotyping assay intended for use as an aid in identifying patients who have specific HLA allele(s) or express specific HLA antigen(s) and may benefit from treatment with a corresponding therapeutic product, or are likely to be at increased risk for serious adverse reactions as a result of treatment with a corresponding therapeutic product.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

FDA 官方分类页: QUK
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。